- Current Environment for Regulatory Authorities and Industry for Latin America
- Harmonization Initiatives, Regulatory Landscape and Clinical Trials in the Latin American Region
- Good Clinical Research Practice
- Drug Safety, Good Clinical and Regulatory Practices Across Latin America
- Pharmacovigilance
- Biotechnology
- Transparency and Predictability
- Emerging Topics
“From an evolving series of Latin American Regulatory Conferences (LARC) held in May 2008 and November 2009 comes this alliance for key stakeholders to influence the advancement for harmonization initiatives within the Latin American local regions,” says Latin American Steering Committee Member Sergio Guerrero, MD, Director, OCA Hospital/Monterrey International Research Center, Mexico.
Register for the 3rd Annual Latin American Regulatory Conference.
ABOUT DIA
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. www.diahome.org
